News & Updates

Majority of patients with chronic pancreatitis also have osteoporosis or osteopenia, with risk factors including older age and lower body mass index, among others, according to a study.

Twelve months of treatment with romosozumab produce marked reductions in new vertebral fractures, especially moderate-to-severe fractures, among postmenopausal women with osteoporosis, according to a study.

Use of tofacitinib for rheumatoid arthritis (RA) may lead to reactivation of hepatitis B virus (HBV), especially among hepatitis B surface antigen-positive (HBsAg+) and HBsAg-negative/hepatitis B core antibody-positive (HBsAg–/HBcAb+) patients, according to a study from Taiwan.